Chromocell Therapeutics Corporation (NYSE American: CHRO) today announced that its board of directors (the “Board of Directors”) has authorized a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE